Prostatilen / Samprost
9 indexed publications · 6 human studies · research from 1991 to 2026
Research goals studied
- Bone, muscle & performance
- Hormonal & reproductive
Studies referencing Prostatilen / Samprost
Effect of Prostate-Derived Complex Peptide Preparations on Erectile Function and Penile Arteriolar Blood Flow in Chronic Prostatitis
2026 · Human evidence
In 50 patients, a Prostatilen-containing regimen was associated with improved questionnaire scores and penile blood-flow measures; no control group was described in the indexed abstract.
Prostatilen-AC with Zinc Arginyl-Glycinate in Chronic Prostatitis
2022 · Human evidence
Assessed a combined prostate-peptide formulation; component-specific effects cannot be isolated.
Vitaprost Forte and Samprost in Urological Practice: Review of Prostate Peptide Preparations
2017 · Preclinical
Reviews clinical use of prostate-derived peptide preparations.
Peptide Bioregulator Chitomur in Benign Prostatic Hyperplasia
2013 · Human evidence
Examined a peptide bioregulator in BPH; direct equivalence to Samprost or Prostatilen should not be assumed.
Comparative Experimental Study of Samprost and Related Prostate Peptide Preparations
2011 · Preclinical
Compared prostate-derived peptide preparations in an experimental setting.
Prostatilen in Patients with Prostatic Adenoma
2006 · Human evidence
Older clinical report evaluating Prostatilen in prostate adenoma.
Effects of Prostatilen on Smooth-Muscle Organs
1999 · Preclinical
Investigated smooth-muscle responses to Prostatilen in experimental systems.
Effect of Prostatilen on Hemostasis
1997 · Human evidence
Reported changes in hemostatic measures during Prostatilen use.
Use of Prostatilen in Chronic Prostatitis
1991 · Human evidence
An older report involving 307 patients; contemporary controlled confirmation is limited.
Working with Prostatilen / Samprost?
Convert a vial to draw volume on the peptide calculator, or track protocols and vials in the free app.
Start tracking free